YCM
PGNX

Yakira Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Yakira Capital Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-825,438
Closed -$3.14M – 180
2020
Q1 		$3.14M Buy
+825,438
New +$3.56M 1.09% 28

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Yakira Capital Management's PGNX Position: Q2 2020 in Review

Yakira Capital Management sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 825,438 shares — an estimated $3.14M sold.

Yakira Capital Management first reported a position in PGNX in Q1 2020 and held it in 1 quarter. The position peaked at $3.14M in Q1 2020. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Yakira Capital Management reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Yakira Capital Management sold 825,438 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $3.14M.
  • Yakira Capital Management first reported a position in Progenics Pharmaceuticals Inc in Q1 2020 and held it in 1 quarter.
  • Yakira Capital Management's Progenics Pharmaceuticals Inc position peaked at $3.14M in Q1 2020.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Yakira Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.